A potential ‘game changer’ for eye disease
By Jan Jarvis
A novel pharmacological intervention to control retinal ganglion cell death caused by glaucoma is in preclinical development, said Katalin Prokai-Tatrai, PhD, Associate Professor in the Center for Neuroscience Discovery and the Department of Pharmaceutical Sciences in the UNT System College of Pharmacy.
“We believe that this novel therapeutic intervention will be effective for other blinding eye diseases associated with neurodegeneration, such as age-related macular degeneration,” said Dr. Prokai-Tatrai. “We are very hopeful we will generate data that shows we can prevent and stop the damage that leads to blindness.
“If it works, it will be a game-changer in terms of how neurodegenerative eye diseases are treated.”
Initially the study will target the effectiveness of the drug for glaucoma, the second-leading cause of blindness. The study will then be expanded to treat other neurodegenerative diseases impacting the brain.
“The beauty of our drug is that it remains inactive until it reaches the retina when applied in eye drops,” Dr. Prokai –Tatrai said.
Scientists know that glaucoma is caused by elevated pressure, but the mechanism behind it is not fully clear. Several possibilities are under investigation. Dr. Prokai-Tatrai said her translational research focuses on neuroprotection, not the mechanism that causes the elevated pressure.
“Our goal is to prevent neuron death using the eye drops, because once those neurons die they are gone forever,” she said. “Our preliminary data is unprecedented and very promising in terms of preserving visual acuity.
“This gives us hope, that if the approach is successful, we can develop a complementary therapy used together with conventional medications for those with glaucoma.”
The multidisciplinary research involves medicinal chemistry-driven drug discovery and delivery, retina proteomics and ophthalmology and is in collaboration with other researchers at UNTHSC and at the University of Missouri-Kansas City School of Medicine.
By Sally Crocker Three nationally known alcohol and substance abuse researchers -- Dr. Melissa A. Lewis, Dr. Dana M. Litt and Dr. Eun-Young Mun – have been appointed to the UNTHSC School of Public Health faculty, underlining the school’s intent to become a national center of excellence in...Read more
Jan 22, 2018
By Jan Jarvis Forty-six UNT Health Science Center physicians have been recognized as Top Doctors, as selected by their peers for listings in Texas Monthly, Fort Worth Magazine and 360 West. Three UNTHSC physicians from Geriatrics have been recognized as Super Doctors by Texas Monthly...Read more
Jan 18, 2018
By Jan Jarvis As someone who enjoys a good meal, Molly Chang was eager to sample the different dishes that are cooked each week in the Culinary Medicine course. “I love trying out recipes and eating new foods, so cooking with friends and getting a free meal is right up my alley,”...Read more
Jan 17, 2018
By Alex Branch A 2015 School of Health Professions graduate will help put injured Miami Marlins baseball players back on the playing field this summer. Steve Carlin PT, DPT, will treat players throughout the organization as the rehabilitation coordinator at the Marlins spring training faci...Read more
Jan 9, 2018